Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000471719 | SCV000552342 | likely benign | Tuberous sclerosis 1 | 2023-09-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001016836 | SCV001177835 | uncertain significance | Hereditary cancer-predisposing syndrome | 2022-12-12 | criteria provided, single submitter | clinical testing | The p.L965I variant (also known as c.2893T>A), located in coding exon 20 of the TSC1 gene, results from a T to A substitution at nucleotide position 2893. The leucine at codon 965 is replaced by isoleucine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Genome- |
RCV000471719 | SCV002040306 | uncertain significance | Tuberous sclerosis 1 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Gene |
RCV002525597 | SCV003194926 | likely benign | not provided | 2023-01-21 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |